Skip Navigation LinksHome > January/February 2013 - Volume 19 - Issue 1 > Histologic and Cytologic Effects of Vaginal Estrogen in Wome...
Female Pelvic Medicine & Reconstructive Surgery:
doi: 10.1097/SPV.0b013e318278cc40
Original Article

Histologic and Cytologic Effects of Vaginal Estrogen in Women With Pelvic Organ Prolapse: A Randomized Controlled Trial

Vaccaro, Christine M. DO*; Mutema, George K. MD; Fellner, Angela N. PhD; Crisp, Catrina C. MD§; Estanol, Maria V. MD§; Kleeman, Steven D. MD§; Pauls, Rachel N. MD§

Collapse Box


Objective: This study aimed to evaluate the histologic and cytologic effects of preoperative vaginal estrogen in women with atrophic vaginitis and pelvic organ prolapse.

Methods: Forty-two women with atrophic vaginitis and stage greater than or equal to 2 prolapse were enrolled in this assessor-blinded randomized controlled trial comparing daily vaginal estrogen cream use for 2 to 12 weeks preoperatively versus no intervention. Data were analyzed using t test and analysis of variance.

Results: Of these 42 women, 22 received treatment and 20 were controls. After a mean 7 (3) weeks of use, the vaginal maturity index increased 15.5% in the treatment group and declined 1.5% in the control group (P < 0.001). The vaginal epithelial thickness was 339 (96) μm in the treatment group compared to 302 (119) μm (P = 0.275) in the controls.

Conclusions: Preoperative vaginal estrogen application for 2 to 12 weeks restores vaginal cytology to premenopausal levels, but does not increase vaginal epithelial thickness in women with prolapse.

© 2013 by Wolters Kluwer Health | Lippincott Williams & Wilkins


Article Tools


Article Level Metrics

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.